• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4和T7噬菌体在定殖有大肠杆菌的无菌小鼠体内的复制

In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.

作者信息

Weiss Marietta, Denou Emmanuel, Bruttin Anne, Serra-Moreno Ruth, Dillmann Marie-Lise, Brüssow Harald

机构信息

Nestlé Research Center, Nestec Ltd P.O. Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland.

出版信息

Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.

DOI:10.1016/j.virol.2009.07.020
PMID:19699505
Abstract

The gut transit of T4 phages was studied in axenic mice mono-colonized with the non-pathogenic Escherichia coli strain K-12. Thirty minutes, 1 and 2 h after phage feeding, T4 phage had reached the jejunum, ileum and cecum, respectively. Phage was found in the lumen and was also associated with the mucosa. One day later no phage was detected in the feces. Compared to germ-free control animals, oral T4 phage led to a 300-fold higher fecal phage titer in mice mono-colonized with E. coli strain WG-5. The in vivo T4 phage replication was transient and reached peak fecal titers about 8 h after oral phage application followed by a rapid titer decrease over two days. Similar data were obtained in mice colonized with E. coli strain Nissle. In contrast, orally applied T7 phage experienced a massive and sustained in vivo replication in mice mono-colonized with E. coli strain WG-5 irrespective whether phage or E. coli host was applied first. T7 phage replication occurred mainly in the large intestine. High titers of T7 phage and high E. coli cell counts coexisted in the feces. The observation of only 20% T7 phage-resistant fecal E. coli colonies suggests a refuge model where phage-sensitive E. coli cells are physically or physiologically protected from phage infection in the gut. The difference between T7 and T4 with respect to gut replication might partly reflect their distinct in vitro capacity to replicate on slowly growing cells.

摘要

在无菌小鼠中,用非致病性大肠杆菌菌株K-12进行单菌定植,研究了T4噬菌体在肠道中的转运情况。噬菌体喂食后30分钟、1小时和2小时,T4噬菌体分别到达空肠、回肠和盲肠。在肠腔中发现了噬菌体,并且它也与粘膜相关。一天后,在粪便中未检测到噬菌体。与无菌对照动物相比,口服T4噬菌体使用大肠杆菌菌株WG-5单菌定植的小鼠粪便噬菌体滴度提高了300倍。体内T4噬菌体复制是短暂的,口服噬菌体后约8小时达到粪便滴度峰值,随后在两天内滴度迅速下降。在用大肠杆菌菌株Nissle定植的小鼠中也获得了类似的数据。相比之下,口服的T7噬菌体在使用大肠杆菌菌株WG-5单菌定植的小鼠中经历了大量且持续的体内复制,无论噬菌体还是大肠杆菌宿主是先施用的。T7噬菌体复制主要发生在大肠中。粪便中存在高滴度的T7噬菌体和高大肠杆菌细胞计数。仅观察到20%对T7噬菌体有抗性的粪便大肠杆菌菌落,这表明存在一种庇护模型,即肠道中对噬菌体敏感的大肠杆菌细胞在物理上或生理上受到保护,免受噬菌体感染。T7和T4在肠道复制方面的差异可能部分反映了它们在体外在缓慢生长细胞上复制的不同能力。

相似文献

1
In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.T4和T7噬菌体在定殖有大肠杆菌的无菌小鼠体内的复制
Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.
2
In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.大肠杆菌噬菌体的体外和体内溶菌活性:对噬菌体疗法的启示
Antimicrob Agents Chemother. 2004 Jul;48(7):2558-69. doi: 10.1128/AAC.48.7.2558-2569.2004.
3
Escherichia coli detection by GFP-labeled lysozyme-inactivated T4 bacteriophage.利用绿色荧光蛋白标记的溶菌酶灭活T4噬菌体检测大肠杆菌
J Biotechnol. 2004 Oct 19;114(1-2):11-20. doi: 10.1016/j.jbiotec.2004.05.011.
4
Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice.噬菌体鸡尾酒疗法用于控制小鼠胃肠道中大肠杆菌O157:H7的研究
J Biosci Bioeng. 2005 Sep;100(3):280-7. doi: 10.1263/jbb.100.280.
5
Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.口服大肠杆菌噬菌体T4的人类志愿者:噬菌体疗法的安全性测试。
Antimicrob Agents Chemother. 2005 Jul;49(7):2874-8. doi: 10.1128/AAC.49.7.2874-2878.2005.
6
T4 phages against Escherichia coli diarrhea: potential and problems.针对大肠杆菌性腹泻的T4噬菌体:潜力与问题
Virology. 2009 May 25;388(1):21-30. doi: 10.1016/j.virol.2009.03.009. Epub 2009 Apr 1.
7
Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.展示于T4噬菌体表面的经口服递送的口蹄疫病毒衣壳原聚体疫苗:对小鼠效力挑战的100%保护率
Vaccine. 2008 Mar 10;26(11):1471-81. doi: 10.1016/j.vaccine.2007.12.053. Epub 2008 Jan 24.
8
[Effect of orally administered bovine lactoferrin and bovine IgG on the establishment of Escherichia coli in the digestive tract of gnotobiotic mice and human newborn infants].[口服牛乳铁蛋白和牛免疫球蛋白对无菌小鼠和人类新生儿消化道中大肠杆菌定植的影响]
Ann Microbiol (Paris). 1983 Nov-Dec;134B(3):429-41.
9
Chemostat modeling of Escherichia coli persistence in conventionalized mono-associated and streptomycin-treated mice.在常规单联和链霉素处理小鼠中大肠杆菌持续性的恒化器模型
Can J Microbiol. 2001 Jan;47(1):86-90.
10
A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum, and Escherichia coli in the mouse gut.小鼠肠道中约氏乳杆菌、长双歧杆菌和大肠杆菌的微宇宙。
DNA Cell Biol. 2009 Aug;28(8):413-22. doi: 10.1089/dna.2009.0873.

引用本文的文献

1
Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage.通过工程噬菌体在哺乳动物肠道中实现蛋白质的持续原位产生和释放。
Nat Biotechnol. 2025 Feb 18. doi: 10.1038/s41587-025-02570-7.
2
Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae.快速设计噬菌体鸡尾酒以抑制肠道定植的耐碳青霉烯类肺炎克雷伯菌的负担和毒力。
Cell Host Microbe. 2024 Nov 13;32(11):1988-2003.e8. doi: 10.1016/j.chom.2024.09.004. Epub 2024 Oct 4.
3
Metapopulation model of phage therapy of an acute lung infection.
噬菌体治疗急性肺部感染的复合种群模型。
mSystems. 2024 Oct 22;9(10):e0017124. doi: 10.1128/msystems.00171-24. Epub 2024 Sep 4.
4
High throughput platform technology for rapid target identification in personalized phage therapy.高通量平台技术在个性化噬菌体治疗中的快速靶标鉴定。
Nat Commun. 2024 Jul 11;15(1):5626. doi: 10.1038/s41467-024-49710-2.
5
Metapopulation model of phage therapy of an acute lung infection.急性肺部感染噬菌体治疗的集合种群模型
bioRxiv. 2024 Jan 31:2024.01.31.578251. doi: 10.1101/2024.01.31.578251.
6
Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons.关于使肠道免受多重耐药菌定植的当前策略的见解:利弊
Antibiotics (Basel). 2023 Jun 19;12(6):1074. doi: 10.3390/antibiotics12061074.
7
Phage Therapy for Mosquito Larval Control: a Proof-of-Principle Study.噬菌体疗法防治蚊虫幼虫:原理验证研究。
mBio. 2022 Dec 20;13(6):e0301722. doi: 10.1128/mbio.03017-22. Epub 2022 Nov 29.
8
Phenotypic flux: The role of physiology in explaining the conundrum of bacterial persistence amid phage attack.表型变化:生理学在解释噬菌体攻击下细菌持续存在之谜中的作用。
Virus Evol. 2022 Sep 15;8(2):veac086. doi: 10.1093/ve/veac086. eCollection 2022.
9
A Metabolite Produced by Gut Microbes Represses Phage Infections in .肠道微生物产生的一种代谢物抑制噬菌体感染。
ACS Chem Biol. 2022 Sep 16;17(9):2396-2403. doi: 10.1021/acschembio.2c00422. Epub 2022 Aug 12.
10
Mutualistic interplay between bacteriophages and bacteria in the human gut.人体肠道中噬菌体和细菌的共生相互作用。
Nat Rev Microbiol. 2022 Dec;20(12):737-749. doi: 10.1038/s41579-022-00755-4. Epub 2022 Jun 30.